UDP-glucuronosyltransferase, the role of the amino terminus in dimerization

被引:95
作者
Meech, R [1 ]
Mackenzie, PI [1 ]
机构
[1] FLINDERS UNIV S AUSTRALIA,MED CTR,DEPT CLIN PHARMACOL,SCH MED,BEDFORD PK,SA 5042,AUSTRALIA
关键词
D O I
10.1074/jbc.272.43.26913
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
UDP-glucuronosyltransferases (UGTs) comprise an important enzyme system in mammals that is involved in detoxification of a variety of small hydrophobic compounds of both endogenous and exogenous origin, Some evidence suggests that these enzymes may function as oligomers; however, little is known about the domain of interaction or the mechanism of oligomerization, In this work, evidence for a functional dimerization between UGTs is provided by studies on mutated forms of UGTSB1. When two inactive forms of UGT2B1 were coexpressed in cell culture, catalytic activity was restored, indicating that UGT2B1 forms functional dimers. To delineate the dimerization domain, inactive fusion proteins containing the amino-or carboxyl-terminal domains of UGT2B1 were generated and expressed with active UGT2B1, Expression of a fusion protein containing only the amino-terminal half of UGT2B1 with active UGT2B1 caused a reduction in UGT2B1 catalytic activity, This reduction in activity was not observed when UGT2B1 was co-expressed with a fusion protein containing only the carboxyl terminal half of UGT2B1, strongly suggesting that the amino-terminal domain is involved in dimerization. Truncation of the immediate amino terminus of UGT2B1 abolished UGT2B1 activity and dimer formation. Activity was also abolished by an L4R substitution in this region of the mature protein, which is highly conserved in the UGT family. These results indicate that UGTs can interact through their amino-terminal domains to form catalytically active dimers. Possible mechanisms resulting in the formation and stabilization of the UGT2B1 dimer are discussed.
引用
收藏
页码:26913 / 26917
页数:5
相关论文
共 24 条
[1]   ALBUMIN REDHILL (-1 ARG, 320 ALA-] THR) - A GLYCOPROTEIN VARIANT OF HUMAN-SERUM ALBUMIN WHOSE PRECURSOR HAS AN ABERRANT SIGNAL PEPTIDASE CLEAVAGE SITE [J].
BRENNAN, SO ;
MYLES, T ;
PEACH, RJ ;
DONALDSON, D ;
GEORGE, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :26-30
[2]   UDP-GLUCURONOSYLTRANSFERASES [J].
BURCHELL, B ;
COUGHTRIE, MWH .
PHARMACOLOGY & THERAPEUTICS, 1989, 43 (02) :261-289
[3]   ANTITHROMBIN DUBLIN (-3 VAL-]GLU) - AN N-TERMINAL VARIANT WHICH HAS AN ABERRANT SIGNAL PEPTIDASE CLEAVAGE SITE [J].
DALY, M ;
BRUCE, D ;
PERRY, DJ ;
PRICE, J ;
HARPER, PL ;
OMEARA, A ;
CARRELL, RW .
FEBS LETTERS, 1990, 273 (1-2) :87-90
[4]   RADIATION INACTIVATION ANALYSIS OF MICROSOMAL UDP-GLUCURONOSYLTRANSFERASES CATALYZING MONOGLUCURONIDE AND DIGLUCURONIDE FORMATION OF 3,6-DIHYDROXYBENZO(A)PYRENE AND 3,6-DIHYDROXYCHRYSENE [J].
GSCHAIDMEIER, H ;
BOCK, KW .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (08) :1545-1549
[5]   Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes [J].
Ikushiro, S ;
Emi, Y ;
Iyanagi, T .
BIOCHEMISTRY, 1997, 36 (23) :7154-7161
[6]   Crigler-Najjar syndrome type II is inherited both as a dominant and as a recessive trait [J].
Koiwai, O ;
Aono, S ;
Adachi, Y ;
Kamisako, T ;
Yasui, Y ;
Nishizawa, M ;
Sato, H .
HUMAN MOLECULAR GENETICS, 1996, 5 (05) :645-647
[7]   PURIFICATION AND IMMUNOCHEMICAL CHARACTERIZATION OF A LOW-PI FORM OF UDP GLUCURONOSYLTRANSFERASE FROM MOUSE-LIVER [J].
MACKENZIE, PI ;
HJELMELAND, LM ;
OWENS, IS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1984, 231 (02) :487-497
[8]  
MACKENZIE PI, 1986, J BIOL CHEM, V261, P6119
[9]  
MACKENZIE PI, 1987, J BIOL CHEM, V262, P9744
[10]  
MACKENZIE PI, 1990, J BIOL CHEM, V265, P3432